American Portfolios Advisors - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 12 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
American Portfolios Advisors ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q3 2022$1,593
-18.2%
2,0000.0%0.00%
Q2 2022$1,948
-0.4%
2,0000.0%0.00%
Q1 2022$1,955
+0.3%
2,0000.0%0.00%
Q4 2021$1,950
-0.8%
2,0000.0%0.00%
Q3 2021$1,966
-0.2%
2,0000.0%0.00%
Q2 2021$1,970
-1.3%
2,0000.0%0.00%
Q1 2021$1,996
+0.3%
2,0000.0%0.00%
Q4 2020$1,990
+2.5%
2,0000.0%0.00%
Q3 2020$1,941
+0.2%
2,0000.0%0.00%
Q2 2020$1,937
+4.6%
2,0000.0%0.00%
Q1 2020$1,851
-2.4%
2,0000.0%0.00%
Q4 2019$1,896
+4.7%
2,0000.0%0.00%
Q3 2019$1,811
-1.0%
2,0000.0%0.00%
Q2 2019$1,829
-0.8%
2,0000.0%0.00%
Q1 2019$1,844
+2.2%
2,0000.0%0.00%
Q4 2018$1,805
-3.5%
2,0000.0%0.00%
Q3 2018$1,871
+0.9%
2,0000.0%0.00%
Q2 2018$1,854
+5.8%
2,0000.0%0.00%
Q1 2018$1,753
-0.1%
2,0000.0%0.00%
Q4 2017$1,7552,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q4 2021
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 70,783,000$69,363,0006.27%
INCOME RESEARCH & MANAGEMENT 14,978,000$14,536,0005.17%
PIPER SANDLER & CO. 5,000,000$4,852,0003.63%
Western Asset Management Company, LLC 42,946,000$42,102,0003.46%
PenderFund Capital Management Ltd. 4,000,000$5,225,0001.45%
Bracebridge Capital, LLC 5,500,000$5,335,0000.85%
WESTWOOD HOLDINGS GROUP INC 43,185,000$42,490,0000.54%
CORBYN INVESTMENT MANAGEMENT INC/MD 1,025,000$995,0000.52%
LMR Partners LLP 22,235,000$21,742,0000.45%
JUPITER ASSET MANAGEMENT LTD 35,000,000$34,357,0000.36%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders